Search Results - Garrido Onecha, M.A.L.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Atezolizumab as treatment of urothelial carcinoma in second line of metastatic disease. Experience in our institution

    Atezolizumab as treatment of urothelial carcinoma in second line of metastatic disease. Experience in our institution by López, L., Garrido Onecha, M.A.L., Távara, B., Pérez, S.L., Vázquez, M., Medina, S., Castanón, C., López, A., García Palomo, A.S., Rodríguez Sánchez, N.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    P241 - Atezolizumab as treatment of urothelial carcinoma in second line of metastatic disease. Experience in our institution

    P241 - Atezolizumab as treatment of urothelial carcinoma in second line of metastatic disease. Experience in our institution by López, L., Garrido Onecha, M.A.L., Távara, B., Pérez, S.L., Vázquez, M., Medina, S., Castanón, C., López, A., García Palomo, A.S., Rodríguez Sánchez, N.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    P174 Tivozanib in first-line treatment of metastatic renal cell carcinoma. Experience in our institution

    P174 Tivozanib in first-line treatment of metastatic renal cell carcinoma. Experience in our institution by López, L., Sánchez Cousido, L.F., Garrido Onecha, M.A.L., Vázquez Díez, M., Pérez, S., Aguilar Borasteros, V., Távara Silva, B., Pedraza Lorenzo, M., Medina Valdivieso, S., García Palomo, A.S., Rodríguez Sánchez, A.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: